Madhavi Sahadevan | Pharmaceutical Science | Women Researcher Award

Women Researcher Award

Madhavi Sahadevan
Thiru Vi Ka Government Arts College

Madhavi Sahadevan
Affiliation Thiru Vi Ka Government Arts College
Country India
Scopus ID 58563556500
Documents 4
Citations 8
h-index 2
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event International Academic Achievements & Awards

Madhavi Sahadevan is a researcher affiliated with Thiru Vi Ka Government Arts College, India, whose scholarly work falls within pharmacology, toxicology and pharmaceutical science. Her publication record is indexed in Scopus under author identifier 58563556500 [1]. She is presented here in connection with the Women Researcher Award at the International Academic Achievements & Awards event [2].

Abstract

This article presents a neutral overview of the scholarly profile of Madhavi Sahadevan, a researcher at Thiru Vi Ka Government Arts College working in pharmacology, toxicology and pharmaceutical science. According to Scopus, her profile lists four documents, eight citations and an h-index of two [1]. The article summarizes her research profile, contributions, bibliometric standing and relevance to the Women Researcher Award [2].

Keywords

Women researcher, pharmacology, toxicology, pharmaceutical science, Scopus, research recognition, academic achievement.

Introduction

Academic recognition programs seek to acknowledge researchers whose work contributes to scientific knowledge and to the visibility of women in research. The Women Researcher Award, presented within the International Academic Achievements & Awards event, is intended to highlight such contributions across disciplines [2]. Madhavi Sahadevan is associated with Thiru Vi Ka Government Arts College in India, a public institution of higher education. Her research activity is documented through the Scopus database, which provides a verifiable record of indexed output [1].

Research Profile

Madhavi Sahadevan’s indexed work is classified under pharmacology, toxicology and pharmaceutical science, a field concerned with the actions of drugs, the safety of chemical substances and the development of therapeutic formulations. Her Scopus record is identified by author ID 58563556500 and currently lists four documents [1].

  • Affiliation: Thiru Vi Ka Government Arts College, India
  • Primary subject area: Pharmacology, Toxicology and Pharmaceutical Science
  • Scopus identifier: 58563556500

Research Contributions

The research contributions of Madhavi Sahadevan are reflected in peer-reviewed publications indexed by Scopus. Work in pharmacology and pharmaceutical science typically advances understanding of bioactive compounds, their mechanisms and their safety profiles. Her publications add to this body of literature and are accessible through the DOI system, which allows readers to consult the original articles directly [3]. Readers are encouraged to consult the primary publications for specific methods and findings [1].

Publications

Scopus lists four documents attributed to Madhavi Sahadevan [1]. The complete and current bibliography, including titles, journals and publication years, is available through her Scopus author profile. Individual articles can be located and cited through their DOIs [3].

Research Impact

Bibliometric indicators offer a limited but useful view of scholarly reach. As recorded in Scopus, Madhavi Sahadevan’s work has received eight citations, and her h-index is two [1]. These figures indicate an early-career or developing research record, and they may change as new publications appear and existing work is cited.

  • Documents: 4
  • Citations: 8
  • h-index: 2

Award Suitability

The Women Researcher Award recognizes women who contribute to research through indexed publications and scholarly engagement [2]. Madhavi Sahadevan’s verifiable Scopus record, her focus on pharmacology, toxicology and pharmaceutical science, and her affiliation with a government arts college provide a documented basis for consideration [1]. Final selection rests with the organizing committee and its stated criteria.

Conclusion

Madhavi Sahadevan is a researcher at Thiru Vi Ka Government Arts College whose indexed work in pharmacology, toxicology and pharmaceutical science is documented in Scopus. With four documents, eight citations and an h-index of two, her record reflects a growing contribution to the field [1]. Her association with the Women Researcher Award highlights the importance of recognizing women in research [2].

References

  1. Elsevier. (n.d.). Scopus author details: Madhavi Sahadevan, Author ID 58563556500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58563556500
  2. Quantum mechanical approaches and molecular docking studies of metal based anticancer drugs cis-Diammine glycolato platinum and Diaminocyclohexane oxalatoplatinum structures.
    https://www.sciencedirect.com/science/article/abs/pii/S1476927123001317
  3. Molecular Docking Studies of Platinum Metal-Based Anticancer Drugs Cis-Diamineglycolatoplatinum and its Derivatives Binding Affinity with Three Different Types of Cancer Cell.
    https://nanobioletters.com/wp-content/uploads/2024/09/LIANBS141.036.pdf

Neeraj Thakur | Pharmacology | Innovative Research Award

Innovative Research Award

Neeraj Thakur
Affiliation University of Oklahoma Health Campus
Country United States
Scopus ID 56645996700
Documents 37
Citations 1,149
h-index 20
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event International Academic Achievements & Awards
ORCID 0000-0003-1758-0737

Neeraj Thakur
University of Oklahoma Health Campus, United States

The Innovative Research Award recognizes sustained scholarly excellence, impactful scientific contributions, and innovation in biomedical and pharmaceutical sciences. Neeraj Thakur has established an active research profile focused on advanced drug delivery systems, nanomedicine, pharmaceutical formulations, biomaterials, and translational therapeutic technologies. His published work demonstrates interdisciplinary collaboration across pharmaceutical science, toxicology, and biomedical engineering while contributing to improved therapeutic delivery strategies for dermatological and ocular applications.[1]

Abstract

Neeraj Thakur’s research integrates pharmaceutical sciences, nanotechnology, biomaterials, and targeted therapeutic delivery to address challenges associated with drug stability, controlled release, tissue targeting, and improved clinical efficacy. His work encompasses hybrid micellar systems, ocular nanoformulations, RNA interference technologies, and advanced pharmaceutical carriers designed to improve patient outcomes through innovative formulation strategies.[2]

Keywords

Drug Delivery Systems, Nanomedicine, Hybrid Micelles, RNA Interference, Corneal Therapeutics, Pharmaceutical Sciences, Targeted Drug Delivery

Introduction

Modern pharmaceutical research increasingly focuses on precision drug delivery, sustained therapeutic release, and biomaterial-enabled treatment strategies. Neeraj Thakur’s research aligns with these objectives through the development of multifunctional nanocarriers and advanced pharmaceutical formulations capable of enhancing therapeutic performance while minimizing adverse effects. His publications demonstrate an interdisciplinary approach combining pharmaceutical sciences with materials engineering and translational medicine.[3]

Research Profile

  • Scopus Author ID: 56645996700
  • 37 indexed scholarly publications.
  • 1,149 citations reflecting broad scientific visibility.
  • h-index of 20 demonstrating consistent research influence.
  • Research spans pharmacology, toxicology, pharmaceutical sciences, nanomedicine and biomaterials.

Research Contributions

The research contributions of Neeraj Thakur include the design of crosslinked hybrid micellar systems for cutaneous drug delivery, sustained nanoformulations for corneal wound healing, and RNA interference applications in viral diagnostics and therapeutics. These investigations emphasize formulation optimization, targeted delivery, therapeutic efficiency, and translational biomedical applications while supporting the broader advancement of pharmaceutical technology.[4]

Publications

  • Crosslinked hybrid micellar platform for targeted cutaneous drug delivery
    Colloids and Surfaces B: Biointerfaces (2026). DOI: 10.1016/j.colsurfb.2026.115998
  • Crosslinked Hybrid Micellar Platform for Targeted Cutaneous Drug Delivery
    Preprint (2026). DOI: 10.2139/ssrn.6250431
  • A multimodal approach to smart and sustained drug delivery for corneal wound management: the GelPol nanoformulation
    Nanomedicine (2025). DOI: 10.1080/17435889.2025.2550236
  • RNAi in viral control and diagnostics
    Book Chapter (2025). DOI: 10.1088/978-0-7503-4987-1ch12

Research Impact

The documented citation profile, publication record, and interdisciplinary research portfolio indicate sustained academic influence within pharmaceutical sciences. Contributions toward targeted drug delivery technologies and nanomedicine support ongoing developments in precision therapeutics, controlled release formulations, and biomedical innovation. The citation metrics further demonstrate recognition by the international research community.[1]

Award Suitability

Based on the available scholarly metrics, publication output, interdisciplinary research contributions, and demonstrated impact within pharmaceutical sciences, Neeraj Thakur represents a suitable candidate for recognition through the Innovative Research Award. His research portfolio reflects innovation in drug delivery technologies, sustained scientific productivity, and contributions supporting future translational healthcare solutions.[2]

Conclusion

Neeraj Thakur has established a notable research profile characterized by innovation in pharmaceutical formulation science, targeted therapeutic delivery, nanotechnology, and biomaterial-based treatment strategies. Supported by strong bibliometric indicators and peer-reviewed scholarly publications, his work contributes to the continued advancement of pharmaceutical sciences and biomedical research while reflecting the qualities recognized by the Innovative Research Award.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Neeraj Thakur, Author ID 56645996700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56645996700
  2. Thakur, N. (2026). Crosslinked hybrid micellar platform for targeted cutaneous drug delivery. Colloids and Surfaces B: Biointerfaces.
    https://doi.org/10.1016/j.colsurfb.2026.115998
  3. Thakur, N. (2026). Crosslinked Hybrid Micellar Platform for Targeted Cutaneous Drug Delivery. SSRN Preprint. https://doi.org/10.2139/ssrn.6250431
  4. Thakur, N. (2025). A multimodal approach to smart and sustained drug delivery for corneal wound management: the GelPol nanoformulation. Nanomedicine. https://doi.org/10.1080/17435889.2025.2550236
  5. Thakur, N. (2025). RNAi in viral control and diagnostics. Viral Diseases: History and New Developments in Diagnostics and Therapeutics.
    https://doi.org/10.1088/978-0-7503-4987-1ch12

Prof. Dr. Petko Marinov | Toxicology | Best Researcher Award

Prof. Dr. Petko Marinov | Toxicology | Best Researcher Award

Prof. Dr. Petko Marinov | Toxicology – PhD at Medical University of Varna, Bulgaria

Professor Petko Marinov is a highly respected academic and clinical expert in the fields of pharmacology, toxicology, and pharmacotherapy. He currently serves as the Dean of the Faculty of Pharmacy at the Medical University of Varna. His work bridges academic leadership with practical clinical knowledge, especially in managing acute intoxications and implementing public health research. Professor Marinov is recognized for his commitment to advancing medical sciences in Bulgaria and his interdisciplinary approach to toxicology and public health issues.

Profile Verified:

Orcid | Google Scholar

Education:

Professor Marinov holds a Master’s degree in Medicine from the Medical University of Varna. His formal education laid the foundation for a distinguished academic career in medical and pharmaceutical sciences. Throughout his educational journey, he has built a solid understanding of pharmacological principles and toxicological practices, which later evolved into academic expertise and research leadership within his university.

Experience:

With an extensive academic and clinical background, Professor Marinov has served in multiple key roles at the Medical University of Varna. As Dean of the Faculty of Pharmacy, he has played a major role in shaping pharmacy education, supervising faculty activities, and encouraging research-led teaching. His professional experience also includes hands-on clinical toxicology, applying advanced treatment methods such as lipid emulsion therapy in real emergency settings. His leadership experience spans educational reform, academic development, and institutional strategy.

Research Interest:

Professor Marinov’s research focuses on clinical toxicology, emergency pharmacotherapy, and public health. He has a particular interest in the use of intravenous lipid emulsions in treating poisoning from lipophilic substances. In addition, he investigates public health concerns such as adolescent alcohol use and examines traditional medical knowledge, including the safe consumption of wild edible mushrooms. His research often combines clinical practice with ethnopharmacological and epidemiological insights, reflecting a deep interdisciplinary focus.

Award:

While no specific individual research awards are listed, Professor Marinov’s appointment as Dean and his consistent record of academic leadership highlight his recognized excellence in the field. His work has earned institutional trust and professional respect, marking him as a key figure in Bulgarian medical academia. These honors position him as a strong candidate for the Best Researcher Award, celebrating both his scientific contributions and leadership.

Publications:

📘 “Epidemiology of Alcohol Intoxications Among Adolescents in Varna Region for 2015–2017 and Study of Parent Behavior” (2021, Journal of IMAB) – An important study on youth alcohol abuse and parental influence. Cited in adolescent public health studies.
🔍 “Analysis of Usage and Quality of Wild Edible Mushrooms by People from Bulgaria, Compared to Other Foreign Countries” (2021, Journal of IMAB) – A comparative study on ethnobotanical knowledge. Referenced in food safety and ethnopharmacology papers.
🌍 “Comparative Investigation of Knowledge of Wild Edible Mushrooms in Varna Region with Other Foreign Geographic Zones” (2021, Journal of IMAB) – Highlights cross-cultural medicinal plant knowledge. Cited by researchers studying regional dietary traditions.
💉 “Lysergic Acid Diethylamide” (2020, Scripta Scientifica Pharmaceutica) – Reviews the pharmacology and toxicology of LSD. Used in references on hallucinogenic substance studies.
🩺 “Intravenous Lipid Emulsion Infusion in Acute Intoxication with Fenitrothion” (2018, Scripta Scientifica Pharmaceutica) – Demonstrates emergency treatment for pesticide poisoning. Cited in toxicology case reports.
💊 “Intravenous Lipid Emulsions – A New Method for the Treatment of Acute Intoxications with Lipophilic Drugs” (2018, Varna Medical Forum) – Explores clinical methods in toxicology. Referenced in pharmacological treatment research.
🧪 “Lipid Emulsions in the Treatment of Acute Poisoning in the Clinic of Toxicology at the Naval Hospital–Varna, Military Medical Academy–Sofia” (2018, Scripta Scientifica Pharmaceutica) – Reports real-case applications in a military clinic. Cited in emergency medicine practice papers.

Conclusion:

Professor Petko Marinov represents a rare combination of scientific insight, clinical expertise, and academic leadership. His research on lipid emulsion therapy, adolescent health behavior, and ethnopharmacology has real-world applications and contributes meaningfully to medical and public health fields. As Dean, he has driven academic excellence and nurtured a research culture in his institution. With a proven track record in impactful research and institutional leadership, Professor Marinov is a highly suitable nominee for the Best Researcher Award.